Kentucky bills · 2026 Regular Session
Kentucky HB 263
AN ACT relating to undesignated glucagon.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
No sponsor recorded.
Summary
Official abstract published by the Kentucky legislature· Summary of Original Version
Create new sections of KRS Chapter 217 to define terms; permit health care practitioners to prescribe and dispense undesignated glucagon in the name of a school; permit authorized entities to receive, possess, and administer undesignated glucagon to a student during diabetic medical emergencies; permit schools to stock undesignated glucagon; provide for immunity from civil liability for any personal injury resulting from good-faith actions to use undesignated glucagon to treat diabetic medical emergencies; require the Cabinet for Health and Family Services to consult the American Diabetes Association when promulgating administrative regulations related to the administration of undesignated glucagon in schools.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 15, 2026 · House
to Health Services (H) - Jan 8, 2026 · House
to Committee on Committees (H) - Jan 8, 2026 · House
introduced in House